Unio Capital’s Thermo Fisher Scientific TMO Stock Holding History

Unio Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,290	Closed	-$660K	–	52
2022 Q3	$660K	Hold	1,290	–	–	0.4%	28
2022 Q2	$701K	Hold	1,290	–	–	0.4%	29
2022 Q1	$762K	Hold	1,290	–	–	0.33%	30
2021 Q4	$434K	Buy	1,290 +650	+102%	+$406K	2.12%	24
2021 Q3	$366K	Hold	640	–	–	0.16%	47
2021 Q2	$323K	Sell	640 -130	-17%	-$61.3K	0.14%	46
2021 Q1	$351K	Hold	770	–	–	0.17%	44
2020 Q4	$359K	Hold	770	–	–	0.18%	46
2020 Q3	$355K	Hold	770	–	–	0.19%	46
2020 Q2	$279K	Hold	770	–	–	0.17%	51
2020 Q1	$218K	Sell	770 -60	-7%	-$18.9K	0.15%	58
2019 Q4	$270K	Sell	830 -100	-11%	-$30.3K	0.16%	59
2019 Q3	$271K	Hold	930	–	–	0.17%	57
2019 Q2	$280K	Buy	930 +75	+9%	+$20.7K	0.17%	54
2019 Q1	$234K	Sell	855 -75	-8%	-$18.7K	0.16%	67
2018 Q4	$208K	Hold	930	–	–	0.16%	66
2018 Q3	$227K	Buy	+930	New	+$214K	0.15%	68

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Unio Capital's TMO Position: Q4 2022 in Review

Unio Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 1,290 shares — an estimated $660K sold.

Unio Capital first reported a position in TMO in Q3 2018 and held it in 17 quarters. The position peaked at $762K in Q1 2022. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Unio Capital reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
Unio Capital sold 1,290 Thermo Fisher Scientific shares in Q4 2022, an estimated $660K.
Unio Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 17 quarters.
Unio Capital's Thermo Fisher Scientific position peaked at $762K in Q1 2022.
2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Unio Capital's 13F filing for Q4 2022, filed 14 Feb 2023.